Literature DB >> 23399958

How long should small lung lesions of ground-glass opacity be followed?

Yoshihisa Kobayashi1, Takayuki Fukui, Simon Ito, Noriyasu Usami, Shunzo Hatooka, Yasushi Yatabe, Tetsuya Mitsudomi.   

Abstract

INTRODUCTION: Pulmonary ground-glass nodules are frequently encountered. The purpose of this study was to evaluate the natural history of them and to gain some insights on how to follow them up.
METHODS: We retrospectively studied patients with pulmonary nodules that met the following criteria: (1) tumor diameter of 3 cm or less, (2) ground-glass opacity proportion of 50% or more, and (3) observation without treatment for 6 months or more. Between 1999 and 2012, 108 pulmonary lesions in 61 patients fulfilled these criteria. We reevaluated their computed tomography images and analyzed changes in their size.
RESULTS: The tumors were 1 cm or lesser in size in 69 lesions, 1.1 cm to 2 cm in 34, and 2.1 cm to 3 cm in five. The proportion of solid lesions was 0% for 82 lesions, 1% to 25% for 19, and 26% to 50 % for seven. At the median observation period of 4.2 years, 29 lesions had become larger, whereas the remaining 79 had persisted without changing in size (±1 mm). The median size change in the nodules that grew was 7 mm (range, 2-32 mm). All 29 tumors began to grow within 3 years of their first observation: 1 year or lesser in 13 lesions, after 1.1 years to 2 years in 12, and after 2.1 years to 3 years in four.
CONCLUSIONS: Some small lung lesions exhibiting ground-glass opacity persisted without changes in size, whereas others grew gradually. The tendency to grow was clear within the first 3 years in all cases. Therefore, we conclude that these lesions should be followed for at least 3 years.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399958     DOI: 10.1097/JTO.0b013e31827e2435

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  37 in total

1.  Persistent pulmonary subsolid nodules with solid portions of 5 mm or smaller: Their natural course and predictors of interval growth.

Authors:  Jong Hyuk Lee; Chang Min Park; Sang Min Lee; Hyungjin Kim; H Page McAdams; Jin Mo Goo
Journal:  Eur Radiol       Date:  2015-09-18       Impact factor: 5.315

2.  Growth of pure ground-glass lung nodule detected at computed tomography.

Authors:  Takatoshi Aoki
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

3.  What do we know about ground-glass opacity nodules in the lung?

Authors:  Choon-Taek Lee
Journal:  Transl Lung Cancer Res       Date:  2015-10

Review 4.  Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy.

Authors:  Hyungjin Kim; Chang Min Park; Jae Moon Koh; Sang Min Lee; Jin Mo Goo
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

Review 5.  Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Authors:  Yoshihisa Kobayashi; Tetsuya Mitsudomi
Journal:  Transl Lung Cancer Res       Date:  2013-10

6.  Persistent pulmonary subsolid nodules: How long should they be observed until clinically relevant growth occurs?

Authors:  Eui Jin Hwang; Chang Min Park
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

7.  Comparison of the effects of model-based iterative reconstruction and filtered back projection algorithms on software measurements in pulmonary subsolid nodules.

Authors:  Julien G Cohen; Hyungjin Kim; Su Bin Park; Bram van Ginneken; Gilbert R Ferretti; Chang Hyun Lee; Jin Mo Goo; Chang Min Park
Journal:  Eur Radiol       Date:  2017-01-05       Impact factor: 5.315

8.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

Review 9.  The IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view.

Authors:  Wentao Fang; Yangwei Xiang; Chenxi Zhong; Qunhui Chen
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

10.  Natural history of pathologically confirmed pulmonary subsolid nodules with deep learning-assisted nodule segmentation.

Authors:  Lin-Lin Qi; Jian-Wei Wang; Lin Yang; Yao Huang; Shi-Jun Zhao; Wei Tang; Yu-Jing Jin; Ze-Wei Zhang; Zhen Zhou; Yi-Zhou Yu; Yi-Zhou Wang; Ning Wu
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.